Joseph Ciaffoni - 01 Dec 2022 Form 4 Insider Report for COLLEGIUM PHARMACEUTICAL, INC (COLL)

Signature
/s/ Colleen Tupper as Attorney-In-Fact For Joseph Ciaffoni
Issuer symbol
COLL
Transactions as of
01 Dec 2022
Net transactions value
-$1,758,618
Form type
4
Filing time
05 Dec 2022, 17:16:47 UTC
Previous filing
30 Nov 2022
Next filing
21 Dec 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction COLL Common Stock Options Exercise $1,218,783 +76,653 +24% $15.90 400,106 01 Dec 2022 Direct
transaction COLL Common Stock Sale $1,722,393 -76,653 -19% $22.47 323,453 01 Dec 2022 Direct F1, F2
transaction COLL Common Stock Sale $1,255,008 -54,400 -17% $23.07 269,053 02 Dec 2022 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction COLL Stock Option (Right to Purchase) Options Exercise $0 -76,653 -100% $0.000000* 0 01 Dec 2022 Common Stock 76,653 $15.90 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2022.
F2 The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.00 to $22.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3).
F3 The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.00 to $23.26, inclusive.
F4 All of the 76,653 option shares are exercisable.